These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 787450)

  • 1. Tobramycin sulfate: a summary of worldwide experience from clinical trials.
    Bendush CL; Weber R
    J Infect Dis; 1976 Aug; 134 Suppl():S219-34. PubMed ID: 787450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tobramycin: an overview.
    Neu HC
    J Infect Dis; 1976 Aug; 134 Suppl():S3-19. PubMed ID: 787451
    [No Abstract]   [Full Text] [Related]  

  • 3. Summary of comparative clinical studies of ceftizoxime and cefamandole, cefazolin and tobramycin.
    Duma RJ
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():303-9. PubMed ID: 6296025
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tobramycin. Bacteriological studies and clinical activity in urinary and extra-urinary infections].
    Abbate GF; Alagia I; Gattoni A; Leonessa V; Manguso L; Altucci P
    G Ital Chemioter; 1977; 24(1-2):33-7. PubMed ID: 615760
    [No Abstract]   [Full Text] [Related]  

  • 5. Tobramycin in the treatment of severe and complicated urinary tract infections.
    Bailey RR; Peddie B
    N Z Med J; 1976 Jul; 84(567):1-3. PubMed ID: 823477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aztreonam: worldwide overview of the treatment of patients with gram-negative infections.
    Henry SA; Bendush CB
    Am J Med; 1985 Feb; 78(2A):57-64. PubMed ID: 3881950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of tobramycin in severe urinary tract infection.
    Bennet AH
    J Infect Dis; 1976 Aug; 134 Suppl():S156-7. PubMed ID: 972285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative clinical efficacy and safety of netilmicin and tobramycin in children with serious gram-negative infections.
    Weippl G
    Clin Ther; 1983; 5(4):342-7. PubMed ID: 6347380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of amikacin and tobramycin in the treatment of infection in patients with cancer.
    Feld R; Valdivieso M; Bodey GP; Rodriguez V
    J Infect Dis; 1977 Jan; 135(1):61-6. PubMed ID: 401853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current state of infectious diseases--potential areas of directed therapy with aztreonam.
    Neu HC
    Am J Med; 1985 Feb; 78(2A):77-80. PubMed ID: 4038580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of tobramycin in respiratory and systemic infections in immunodepressed and normal patients.
    Altucci P; Abbate GF; Alagia I; Leonessa V
    J Infect Dis; 1976 Aug; 134 Suppl():S182-6. PubMed ID: 972280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteriological, clinical, and pharmacological investigations with tobramycin in patients with serious urinary tract infection.
    Iván E; Cstáry KN
    J Infect Dis; 1976 Aug; 134 Suppl():S153-5. PubMed ID: 823274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with tobramycin in the treatment of infections due to gram-negative bacilli.
    Carmalt ED; Cortez LM; Rosenblatt JE
    Am J Med Sci; 1976; 271(3):285-95. PubMed ID: 820195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial therapy in infants and children. Part II. Therapy of infectious conditions.
    McCracken GH; Eichenwald HF
    J Pediatr; 1978 Sep; 93(3):357-77. PubMed ID: 357692
    [No Abstract]   [Full Text] [Related]  

  • 15. [Tobramycin--clinical pharmacology and chemotherapy].
    Periti P
    J Chemother; 1996 Jan; 8 Suppl 1():3-30. PubMed ID: 8948764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ciprofloxacin: an update on clinical experience.
    Arcieri G; Griffith E; Gruenwaldt G; Heyd A; O'Brien B; Becker N; August R
    Am J Med; 1987 Apr; 82(4A):381-6. PubMed ID: 3555063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised, controlled trial of the comparative efficacy, auditory toxicity, and nephrotoxicity of tobramycin and netilmicin.
    Lerner AM; Reyes MP; Cone LA; Blair DC; Jansen W; Wright GE; Lorber RR
    Lancet; 1983 May; 1(8334):1123-6. PubMed ID: 6133153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of aztreonam versus tobramycin for aerobic gram-negative bacilli lower respiratory tract infections.
    Rodriguez JR; Ramirez-Ronda CH
    Am J Med; 1985 Feb; 78(2A):42-3. PubMed ID: 4038578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of results of clinical trials with amikacin.
    Gooding PG; Berman E; Lane AZ; Agre K
    J Infect Dis; 1976 Nov; 134 SUPPL():S441-5. PubMed ID: 792360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of tobramycin in severe infections (author's transl)].
    Babinet P; Bricaire F; Tancrede C; Goulon M
    Sem Hop; 1978 Oct 18-25; 54(33-36):1049-54. PubMed ID: 220716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.